Subjects are randomised to receive posterior fusion using either the CORUS-LX system or the standard posterior fusion method.
The question is no longer whether patients use cannabis — it’s what it means for their surgical outcomes. A recent study takes a closer look at this very issue in patients undergoing elective lumbar ...
HAMILTON, ON and BOSTON, Aug. 29, 2022 /PRNewswire/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results